Literature DB >> 9880591

Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length.

K L Moulder1, O Onodera, J R Burke, W J Strittmatter, E M Johnson.   

Abstract

Recent evidence suggests that, in huntingtin and many other proteins, polyglutamine repeats are a toxic stimulus in neurodegenerative diseases. To investigate the mechanism by which these repeats may be toxic, we transfected primary rat cerebellar granule neurons with polyglutamine-green fluorescent protein (GFP) fusion constructs containing 19 (Q19-GFP), 35 (Q35-GFP), 56 (Q56-GFP), or 80 (Q80-GFP) glutamine residues. All constructs, except Q19-GFP, aggregated within the nuclei of transfected cells in a length- and time-dependent manner. Although Q35-GFP expression led to the development of several small aggregates per cell, these aggregates were cleared or degraded, and the cells remained viable. In contrast, Q80-GFP expression resulted in one or two large aggregates and induced cell death. Caspase activation was observed after Q80-GFP aggregation, but inhibition of caspases with Boc-aspartyl(OMe)-fluoromethylketone (BAF) only served to delay, not prevent, toxicity. In addition, aggregation and toxicity were not affected by other modulators of neuronal cell death such as genetic deletion of the proapoptotic bcl-2 family member bax or addition of the protein synthesis inhibitor cycloheximide. Lastly, nuclear condensation did not occur as part of the toxicity. These data suggest that polyglutamine-GFP expression is toxic to primary neurons but that the death is distinct from classical apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880591      PMCID: PMC6782221     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis.

Authors:  R J Collins; B V Harmon; G C Gobé; J F Kerr
Journal:  Int J Radiat Biol       Date:  1992-04       Impact factor: 2.694

2.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

3.  Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?

Authors:  A J Cooper; K F Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

4.  Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.

Authors:  P Kahlem; C Terré; H Green; P Djian
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.

Authors:  J M Ordway; S Tallaksen-Greene; C A Gutekunst; E M Bernstein; J A Cearley; H W Wiener; L S Dure; R Lindsey; S M Hersch; R S Jope; R L Albin; P J Detloff
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

6.  BAX is required for neuronal death after trophic factor deprivation and during development.

Authors:  T L Deckwerth; J L Elliott; C M Knudson; E M Johnson; W D Snider; S J Korsmeyer
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

7.  Homozygotes for Huntington's disease.

Authors:  N S Wexler; A B Young; R E Tanzi; H Travers; S Starosta-Rubinstein; J B Penney; S R Snodgrass; I Shoulson; F Gomez; M A Ramos Arroyo
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

8.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

Authors:  J Nasir; S B Floresco; J R O'Kusky; V M Diewert; J M Richman; J Zeisler; A Borowski; J D Marth; A G Phillips; M R Hayden
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

9.  In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes.

Authors:  M Dragunow; R L Faull; P Lawlor; E J Beilharz; K Singleton; E B Walker; E Mee
Journal:  Neuroreport       Date:  1995-05-09       Impact factor: 1.837

10.  Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death.

Authors:  T M Miller; K L Moulder; C M Knudson; D J Creedon; M Deshmukh; S J Korsmeyer; E M Johnson
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  20 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin.

Authors:  S H Li; A L Cheng; H Li; X J Li
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

Review 3.  Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

Review 4.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

5.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

6.  Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.

Authors:  Lianwu Fu; Ya-sheng Gao; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2005-06-16       Impact factor: 5.996

7.  Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.

Authors:  Y Chai; S L Koppenhafer; N M Bonini; H L Paulson
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

8.  c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway.

Authors:  M Encinas; M G Tansey; B A Tsui-Pierchala; J X Comella; J Milbrandt; E M Johnson
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

9.  Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.

Authors:  V Panet-Raymond; B Gottlieb; L K Beitel; H Schipper; M Timiansky; L Pinsky; M A Trifiro
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

10.  Microtubule-dependent formation of the stigmoid body as a cytoplasmic inclusion distinct from pathological aggresomes.

Authors:  Ryutaro Fujinaga; Yukio Takeshita; Kanako Uozumi; Akie Yanai; Kazuhiro Yoshioka; Keiji Kokubu; Koh Shinoda
Journal:  Histochem Cell Biol       Date:  2009-07-04       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.